Narges Alipanah-Lechner, MD, MAS

Assistant Professor

Dr. Narges Alipanah-Lechner is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She received her undergraduate degree from Johns Hopkins University and her medical degree and master's degree in clinical and epidemiological research from UCSF. Dr. Alipanah-Lechner's research interest is to apply complementary systems biology approaches within precision medicine to improve the diagnosis and treatment of patients with syndromes of critical illness such as sepsis and ARDS. She currently attends in the intensive care units and the pulmonary function laboratory at UCSF.

Education
M.A.S., 06/2023 - Clinical and Epidemiological Research, UCSF
Fellowship, 06/2022 - Pulmonary and Critical Care Medicine, UCSF
Chief Residency, 06/2019 - Internal Medicine, Santa Clara Valley Medical Center
Residency, 06/2018 - Internal Medicine, Santa Clara Valley Medical Center
M.D., 06/2015 - Medicine, UCSF
B.A., 06/2009 - Public Health, Johns Hopkins University
Honors and Awards
  • Emerging Generation Award, American Society for Clinical Investigation, 2024
Websites
Publications
  1. Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, Fujii T, Giamarellos-Bourboulis EJ, Goligher EC, Gong MN, Karakike E, Liu V, Lumlertgul N, Marshall JC, Menon DK, Meyer NJ, Munroe ES, Myatra SN, Ostermann M, Prescott HC, Randolph AG, Schenck EJ, Seymour CW, Shankar-Hari M, Singer M, Smit MR, Tanaka A, Taccone FS, Thompson BT, Torres LK, Van der Poll T, Vincent JL, Calfee CS. From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations For Developing Precision Medicine in ICU. American journal of respiratory and critical care medicine 2024. PMID: 38687499


  2. Chouchane O, Schuurman AR, Reijnders TDY, Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, Calfee CS, Matthay MA, Langley RJ, Alipanah-Lechner N, Kingsmore SF, Rogers A, Weeghel MV, Vaz FM, van der Poll T. The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired Pneumonia. American journal of respiratory and critical care medicine 2024. PMID: 38240721


  3. Alipanah-Lechner N, Hurst-Hopf J, Delucchi K, Swigart L, Willmore A, LaCombe B, Dewar R, Lane HC, Lallemand P, Liu KD, Esserman L, Matthay MA, Calfee CS, I-SPY COVID Consortium. Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial. Critical care (London, England) 2024. PMID: 38383504


  4. Alipanah-Lechner N, Cavalcanti AB, Diaz J, Ferguson ND, Myatra SN, Calfee CS. From Berlin to Global: The Need for Syndromic Definitions of ARDS. American journal of respiratory and critical care medicine 2023. PMID: 37816094


  5. Alipanah-Lechner N, Neyton L, Mick E, Willmore A, Leligdowicz A, Contrepois K, Jauregui A, Zhuo H, Hendrickson C, Gomez A, Sinha P, Kangelaris KN, Liu KD, Matthay MA, Rogers AJ, Calfee CS. Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS. American journal of physiology. Lung cellular and molecular physiology 2023. PMID: 36648136


  6. Hudson M, Alipanah N, Singh S, Nahid P. Interventions to enhance treatment adherence and retention in care for HIV-TB. 2022. PMID: 35197169


  7. Alipanah N, Calfee CS. Phenotyping in acute respiratory distress syndrome: state of the art and clinical implications. Current opinion in critical care 2022. PMID: 34670998


  8. Shah SJ, Barish PN, Prasad PA, Kistler A, Neff N, Kamm J, Li LM, Chiu CY, Babik JM, Fang MC, Kangelaris KN, Langelier C, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Castaneda G. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19. EClinicalMedicine 2020. PMID: 32864588


  9. Berger CA, Alipanah N, Kheir F, Ruminjo JK, Nahid P, Thomson C. Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis. Annals of the American Thoracic Society 2020. PMID: 32464069


  10. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. medRxiv : the preprint server for health sciences 2020. PMID: 32511538


  11. Shah SJ, Barish PN, Prasad PA, Kistler AL, Neff N, Kamm J, Li LM, Chiu CY, Babick JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Davis JM, Castenada GD, Consortium C, Dadasovich RM, Deng X, DeRisi JL, Detweiler AM, Federman S, Haliburton JR, Hao SL, Kerkhoff AD, Kumar R, Malcolm K, Mann SA, Martinez SP, Marya R, Mick E, Mwakibete LL, Najafi N, Peluso MJ, Phelps MS, Pisco AO, Ratnasiri K, Rubio LA, Sellas AB, Sherwood KD, Sheu J, Spottiswoode N, Tan M, Yu G, Kangelaris KN, Langelier C. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19. medRxiv : the preprint server for health sciences 2020. PMID: 32511488


  12. Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics (Basel, Switzerland) 2019. PMID: 31151255


  13. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. Volume 15 of Issue 7. PLoS medicine 2018. PMID: 29969463


  14. Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P. Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016. PMID: 27776595


  15. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Volume 63 of Issue 7. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016. PMID: 27621353


  16. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Volume 63 of Issue 7. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016. PMID: 27516382


  17. Kaplan AG, Abdelshehid CS, Alipanah N, Zamansani T, Lee J, Kolla SB, Sountoulides PG, Graversen J, Lusch A, Kaufmann OG, Louie M, Clayman RV, McDougall EM. Genitourinary exam skills training curriculum for medical students: a follow-up study of comfort and skill utilization. Volume 26 of Issue 10. Journal of endourology 2012. PMID: 22712690


  18. Alipanah N, Varadhan R, Sun K, Ferrucci L, Fried LP, Semba RD. Low serum carotenoids are associated with a decline in walking speed in older women. Volume 13 of Issue 3. The journal of nutrition, health & aging 2009. PMID: 19262947


  19. Tabarsi P, Baghaei P, Farnia P, Mansouri N, Chitsaz E, Sheikholeslam F, Marjani M, Rouhani N, Mirsaeidi M, Alipanah N, Amiri M, Masjedi MR, Mansouri D. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. Volume 337 of Issue 3. The American journal of the medical sciences 2009. PMID: 19301453


  20. Tabarsi P, Nooraki A, Mirsaeidi M, Amiri M, Baghaei P, Farnia P, Kazempour M, Heidarnazhad H, Alipanah N, Mansouri D, Masjedi MR. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran. Volume 13 of Issue 1. Respirology (Carlton, Vic.) 2008. PMID: 18197919


  21. Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran. Volume 29 of Issue 1. Saudi medical journal 2008. PMID: 18176695